Salubris Biotherapeutics

Developer of antibody therapeutics for the treatment of cancer, cardiovascular and metabolic diseases

placeGaithersburg, Maryland, United States calendar_todayFounded 2016 groups1 employees language salubrisbio.com

Registered entities

Social engagement

Social engagement: 3.4K social following, 7 posts in the last 12 months — below the industry typical range.

Investor mix

1 investor on record.

Investor typeCountShare
Private equity1100%

Recent activity

22 Jan 2026
Event
World ADC London
29 Sep 2025
Milestone
regulatory
Coming soon